Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.

PLoS One · 2022 · PMC9371359 · PMID 35951654

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

One explanation for this may be that early-stage PD was found by screening, in which accelerated progression brought about by DM was not yet significant.

also in 313 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.